4//SEC Filing
Cyclacel Pharmaceuticals, Inc. 4
Accession 0001104659-13-089466
$BGMSCIK 0001130166operating
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 5:23 PM ET
Size
5.6 KB
Accession
0001104659-13-089466
Insider Transaction Report
Form 4
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
- Award
Option
2013-12-09+105,000→ 105,000 totalExercise: $4.61Exp: 2023-12-09→ Common Stock (105,000 underlying)
Footnotes (2)
- [F1]These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
- [F2]These securities were issued as part of the Issuer's annual equity compensation to executive officers.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001130166
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 5:23 PM ET
- Size
- 5.6 KB